|
CDK14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.345660E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.530380E-01 |
| Normal-vs-Stage2 |
2.499900E-02 |
| Normal-vs-Stage3 |
3.698400E-03 |
| Normal-vs-Stage4 |
8.954300E-02 |
| Stage1-vs-Stage2 |
1.472570E-01 |
| Stage1-vs-Stage3 |
4.118100E-02 |
| Stage1-vs-Stage4 |
4.251600E-01 |
| Stage2-vs-Stage3 |
9.304600E-01 |
| Stage2-vs-Stage4 |
6.169400E-01 |
| Stage3-vs-Stage4 |
4.800400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.606100E-02 |
| Normal-vs-AfricanAmerican |
1.70020000000992E-06 |
| Normal-vs-Asian |
6.238800E-01 |
| Caucasian-vs-AfricanAmerican |
1.999500E-04 |
| Caucasian-vs-Asian |
2.084400E-01 |
| AfricanAmerican-vs-Asian |
1.285810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.064200E-03 |
| Normal-vs-Female |
1.236980E-01 |
| Male-vs-Female |
2.970400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.88690000000524E-05 |
| Normal-vs-Age(41-60Yrs) |
1.320250E-01 |
| Normal-vs-Age(61-80Yrs) |
1.535620E-02 |
| Normal-vs-Age(81-100Yrs) |
9.493600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.580700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.004000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.017030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.167200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.375000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.241400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.112200E-01 |
| Normal-vs-Grade 2 |
1.443200E-01 |
| Normal-vs-Grade 3 |
1.654390E-02 |
| Normal-vs-Grade 4 |
3.223500E-03 |
| Grade 1-vs-Grade 2 |
5.155000E-01 |
| Grade 1-vs-Grade 3 |
2.962600E-01 |
| Grade 1-vs-Grade 4 |
1.183580E-01 |
| Grade 2-vs-Grade 3 |
2.752800E-01 |
| Grade 2-vs-Grade 4 |
5.270300E-02 |
| Grade 3-vs-Grade 4 |
2.502400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.648800E-01 |
| Normal-vs-ccB subtype |
1.400470E-04 |
| ccA subtype-vs-ccB subtype |
1.13339999996409E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.378400E-02 |
| Normal-vs-N1 |
2.135700E-02 |
| N0-vs-N1 |
3.080000E-01 |
|
|
